Generation of induced pluripotent stem cells (iPSCs) derived from intractable retinal disease patients and clarification of the diseases and novel therapies development by using retinal tissues differentiated and induced from iPSC.

Generation of induced pluripotent stem cells (iPSCs) derived from intractable retinal disease patients and clarification of the diseases and novel therapies development by using retinal tissues differentiated and induced from iPSC. - Generation of induced pluripotent stem cells (iPSCs) derived from intractable retinal disease patients and clarification of the diseases and novel therapies development by using retinal tissues differentiated and induced from iPSC.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021556

Enrollment

Registered

2016-03-22

Start date

2016-04-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intractable retinal diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Intractable retinal diseases (glaucoma, optic nerve atrophy, retinal choroidal dystrophy, retinal degeneration disease) 20 years of age or more

Exclusion criteria

Exclusion criteria: Under 20 years of age

Design outcomes

Primary

Measure	Time frame
Comparative analysis between the patients and normal people about the morphology, the function, stress response and drug screening of the retinal cells derived from iPSCs.	—

Countries

Japan

Contacts

Public ContactWataru Kobayashi

Tohoku University Graduate School of Medicine Department of Ophthalmology

nishiguchi@oph.med.tohoku.ac.jp022-717-7294

Outcome results